Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV.

Hepatology 2006 Oct;44(4):907-14

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

In patients with chronic hepatitis B virus (HBV), 2 predominant precursor dendritic cell (DC) subtypes, the myeloid dendritic cell (mDC) and the plasmacytoid dendritic cell (pDC), were recently found to be functionally impaired. HBV DNA was found to be present in the DC subtypes, but no viral replication could be detected. The question remains whether simply the presence of the virus and viral proteins causes this dysfunction of DCs. To address this issue, the effect of viral load reduction resulting from treatment with the nucleotide analogue adefovir dipivoxil on the number and functionality of circulating DCs was studied during 6 months of treatment. Treatment resulted in a mean 5 log(10) decrease in the viral load and normalization of alanine aminotransferase within 3 months. The number of mDCs, but not of pDCs, increased significantly over 6 months of treatment to a level comparable to that of uninfected healthy controls. The allostimulatory capacity of isolated and in vitro matured mDCs increased significantly after 3 months of treatment. Accordingly, mDCs exhibited an increased capacity to produce tumor necrosis factor alpha and interleukin-12 after 3-6 months of treatment. There was no change in interferon alpha production by pDCs during treatment. In conclusion, adefovir treatment results in an improvement in the number and functionality of mDCs, but not of pDCs. Our findings provide clues for the reasons why current antiviral therapy does not lead to consistently sustained viral eradication.

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.21340DOI Listing
October 2006
6 Reads

Publication Analysis

Top Keywords

months treatment
16
number functionality
12
dendritic cell
12
patients chronic
8
treatment
8
mdcs pdcs
8
myeloid dendritic
8
increased months
8
viral load
8
viral
5
months
5
decrease viral
4
conclusion adefovir
4
log10 decrease
4
adefovir treatment
4
treatment treatment
4
treatment log10
4
load normalization
4
factor alpha
4
months number
4

References

(Supplied by CrossRef)

Beasley et al.
Cancer 1988

Lok et al.
N Engl J Med 2002

Chisari et al.
Annu Rev Immunol 1995

Webster et al.
HEPATOLOGY 2000

Maini et al.
Gastroenterology 1999

Maini et al.
J Exp Med 2000

Marinos et al.
HEPATOLOGY 1995

Van der Molen et al.
HEPATOLOGY 2004

Stoop et al.
HEPATOLOGY 2005

Gad et al.
Immunology 2004

Beckebaum et al.
Clin Immunol 2002

Similar Publications